45 related articles for article (PubMed ID: 3561327)
1. The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study.
Shinagawa T; Kitamura T; Katanoda K; Matsuda T; Ito Y; Sobue T
Int J Cancer; 2017 Feb; 140(3):618-625. PubMed ID: 27778323
[TBL] [Abstract][Full Text] [Related]
2. Results of mass screening for neuroblastoma in 18-month-old infants in Osaka area, Japan.
Yamamichi T; Oue T; Irie A; Inoue M; Takama Y; Nomura M; Yoneda A; Okuyama H; Usui N
Pediatr Surg Int; 2021 Dec; 37(12):1645-1649. PubMed ID: 34519853
[TBL] [Abstract][Full Text] [Related]
3. Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age: A Population-Based Study in Osaka, Japan.
Ioka A; Inoue M; Yoneda A; Nakamura T; Hara J; Hashii Y; Sakata N; Yamato K; Tsukuma H; Kawa K
J Epidemiol; 2016; 26(4):179-84. PubMed ID: 26548355
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma screening in Japan: population-based cohort study and future aspects of screening.
Hiyama E
Ann Acad Med Singap; 2008 Dec; 37(12 Suppl):88-4. PubMed ID: 19904462
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up results of the observation program for neuroblastoma detected at 6-month mass screening.
Arakawa A; Oguma E; Aihara T; Kishimoto H; Kikuchi A; Hanada R; Koh K
J Pediatr; 2014 Oct; 165(4):855-7.e1. PubMed ID: 25091258
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of nationwide screening program for neuroblastoma in Japan.
Hisashige A;
Glob J Health Sci; 2014 Apr; 6(4):94-106. PubMed ID: 25001552
[TBL] [Abstract][Full Text] [Related]
7. Secular trends in neuroblastoma mortality before and after the cessation of national mass screening in Japan.
Katanoda K; Hayashi K; Yamamoto K; Sobue T
J Epidemiol; 2009; 19(5):266-70. PubMed ID: 19652443
[TBL] [Abstract][Full Text] [Related]
8. Neuroblastoma arising from the celiac ganglion.
Ito F; Ito T; Ando H; Seo T
Pediatr Surg Int; 1996 Dec; 11(1):52-3. PubMed ID: 24057473
[TBL] [Abstract][Full Text] [Related]
9. Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
Hishiki T; Matsumoto K; Ohira M; Kamijo T; Shichino H; Kuroda T; Yoneda A; Soejima T; Nakazawa A; Takimoto T; Yokota I; Teramukai S; Takahashi H; Fukushima T; Kaneko T; Hara J; Kaneko M; Ikeda H; Tajiri T; Nakagawara A;
Int J Clin Oncol; 2020 Sep; 25(9):1744-1745. PubMed ID: 32749556
[TBL] [Abstract][Full Text] [Related]
10. Reply to K. Beiske et al.
Sokol E; Desai AV; Applebaum MA; Valteau-Couanet D; Park JR; Pearson ADJ; Schleiermacher G; Irwin MS; Hogarty M; Naranjo A; Volchenboum S; Cohn SL; London WB
J Clin Oncol; 2020 Nov; 38(31):3720-3721. PubMed ID: 32931402
[No Abstract] [Full Text] [Related]
11. Presacral neuroblastoma in an 11-month-old infant.
Malik S; Saran S; Kharbanda A
Sudan J Paediatr; 2018; 18(1):87-89. PubMed ID: 30166769
[No Abstract] [Full Text] [Related]
12. Mass Screening.
Can Med Assoc J; 1965 Jan; 92(4):193-4. PubMed ID: 20328092
[No Abstract] [Full Text] [Related]
13. Genetic lineages of undifferentiated-type gastric carcinomas analysed by unsupervised clustering of genomic DNA microarray data.
Sonoda A; Mukaisho K; Nakayama T; Diem VT; Hattori T; Andoh A; Fujiyama Y; Sugihara H
BMC Med Genomics; 2013 Jul; 6():25. PubMed ID: 23866769
[TBL] [Abstract][Full Text] [Related]
14. Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous?
Nakayama T; Ling ZQ; Mukaisho K; Hattori T; Sugihara H
BMC Cancer; 2010 Jun; 10():311. PubMed ID: 20565940
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma mass screening in infancy in Kyoto, Japan.
Sawada T; Kawakatsu H; Sugimoto T; Horii Y; Kuroda K; Hosoi H; Saida T; Hino T; Michihata T
Indian J Pediatr; 1987; 54(6):874-82. PubMed ID: 3440599
[No Abstract] [Full Text] [Related]
16. Screening for neuroblastoma.
Draper GJ
BMJ; 1988 Jul; 297(6642):152-3. PubMed ID: 3408950
[No Abstract] [Full Text] [Related]
17. Advances in managing childhood cancer.
Jones PM
Br Med J (Clin Res Ed); 1987 Jul; 295(6589):4-6. PubMed ID: 3113607
[No Abstract] [Full Text] [Related]
18. Number and cure rate of neuroblastoma cases detected by the mass screening program in Japan: future aspects.
Sawada T; Sugimoto T; Tanaka T; Kawakatsu H; Ishii T; Matsumura T; Horii Y
Med Pediatr Oncol; 1987; 15(1):14-7. PubMed ID: 3561327
[TBL] [Abstract][Full Text] [Related]
19. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
